Literature DB >> 33618120

Feasibility and efficacy of a physical activity intervention for managing restless legs syndrome in multiple sclerosis: Results of a pilot randomized controlled trial.

Katie L J Cederberg1, Robert W Motl2.   

Abstract

BACKGROUND: This pilot randomized controlled trial examined the feasibility and efficacy of a physical activity behavior change intervention for improving restless legs syndrome (RLS) severity and secondary sleep outcomes among a sample of adults with multiple sclerosis (MS).
METHODS: Participants with MS(N=15) were randomly assigned into intervention(n=8) or waitlist control(n=7) conditions. The physical activity intervention was delivered over a 16-week period and outcomes were assessed at baseline and immediately following the 16-week period in both conditions.
RESULTS: There was a significant, positive effect of the intervention on overall RLS severity (p=.01;ηρ2=.43), severity during the night(p=.03,ηρ2=.35), severity during the day while resting(p=.01,ηρ2=.44), and severity during the day while active(p<.01,ηρ2=.61), and non-significant improvements in RLS severity while falling asleep (p=.33,ηρ2=.09). There were significant positive effects on sleep satisfaction(p<.01,ηρ2=.49) and non-significant improvements in self-reported global sleep quality(p=.35,ηρ2=.08). There was a significant intervention effect on self-reported time in bed(p=.03,ηρ2=.37) and total sleep time(p=.03,ηρ2=.36), and non-significant improvements in self-reported sleep latency (p=.08,ηρ2=.25), sleep efficiency(p=.27,ηρ2=.11), and daytime sleepiness (p=.52,ηρ2=.04;p=.35,ηρ2=.08;p=.51,ηρ2=.04). There was no significant effect of the intervention on device-measured sleep quality.
CONCLUSIONS: We provide preliminary evidence for the feasibility and efficacy of a physical activity intervention for reducing RLS severity and potentially improving self-reported sleep outcomes in adults with MS. CLINICALTRIALS. GOV IDENTIFICATION NUMBER: NCT04061681.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Multiple sclerosis; Physical activity; RCT; Restless legs syndrome; Sleep

Mesh:

Year:  2021        PMID: 33618120      PMCID: PMC8221038          DOI: 10.1016/j.msard.2021.102836

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  35 in total

1.  Minimal clinically significant change for the International Restless Legs Syndrome Study Group rating scale in clinical trials is a score of 3.

Authors:  Richard P Allen
Journal:  Sleep Med       Date:  2013-08-14       Impact factor: 3.492

2.  Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.

Authors:  Richard P Allen; Daniel L Picchietti; Diego Garcia-Borreguero; William G Ondo; Arthur S Walters; John W Winkelman; Marco Zucconi; Raffaele Ferri; Claudia Trenkwalder; Hochang B Lee
Journal:  Sleep Med       Date:  2014-05-17       Impact factor: 3.492

Review 3.  The role and validity of actigraphy in sleep medicine: an update.

Authors:  Avi Sadeh
Journal:  Sleep Med Rev       Date:  2011-01-14       Impact factor: 11.609

Review 4.  Benefits of Exercise Training in Multiple Sclerosis.

Authors:  Robert W Motl; Brian M Sandroff
Journal:  Curr Neurol Neurosci Rep       Date:  2015-09       Impact factor: 5.081

5.  Reliability and factor analysis of the Epworth Sleepiness Scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1992-08       Impact factor: 5.849

6.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

Review 7.  Strategies for the treatment of restless legs syndrome.

Authors:  Mark J Buchfuhrer
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

8.  Combination of Exercise Training and Dopamine Agonists in Patients with RLS on Dialysis: A Randomized, Double-Blind Placebo-Controlled Study.

Authors:  Christoforos D Giannaki; Giorgos K Sakkas; Christina Karatzaferi; Maria D Maridaki; Yiannis Koutedakis; Georgios M Hadjigeorgiou; Ioannis Stefanidis
Journal:  ASAIO J       Date:  2015 Nov-Dec       Impact factor: 2.872

9.  Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia.

Authors:  Jutta Backhaus; Klaus Junghanns; Andreas Broocks; Dieter Riemann; Fritz Hohagen
Journal:  J Psychosom Res       Date:  2002-09       Impact factor: 3.006

10.  The prevention and handling of the missing data.

Authors:  Hyun Kang
Journal:  Korean J Anesthesiol       Date:  2013-05-24
View more
  1 in total

1.  Discrepancies between self-reported and device-measured sleep parameters in adults with multiple sclerosis.

Authors:  Katie L J Cederberg; Brianna G Mathison; Morgan L Schuetz; Robert W Motl
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.